As announced in the end of 2019, Instant NanoBiosensors has been chosen to participate as one of twelve global start-ups, in the Merck Accelerator Program 2020! Alongside 11 other aspring start ups, our team will be for the next three months based in the Merck Innovation Center in Darmstadt, Germany. Our targets are to kick off potential partnerships and to learn from the science and technology giant Merck.Read more about all 12 participating start ups on the official Merck website.
In the end of December 2019, our CEO and Co-Founder Tony Chung has been interviewed by the recognized industry journal EE Times Asia. We are more than grateful about this recognized journal publication of Instant NanoBiosensors ambitions with its revolutionary FOPPR™ technology. Read the full interview, on the EE Times Asia website.
Instant NanoBiosensors is in the Korean and Japanese markets! Our INB-D200 Biomarker Analyzer is now available in Korea and Japan. Please visit our distributors' websites for more details.PhileKorea (Korea): http://www.philekorea.co.kr/kor/bbs/product.php?idx=322#phileTab0BM Equipment (Japan): https://www.bmbio.com/product/tabid73.html?pdid1=INB-D200-2CH
Congratulations to Instant NanoBiosensors for being selected as one of the twelve teams to participate in the Merck Accelerator Program! Our state-of-the-art optical fiber/nanomaterials/microfluidics FOPPR technology allows us to stand out among over 600 startups from all over the world! We are the only startup selected from Asia and will be based in the Merck Innovation Center beginning in January of 2020 for three months to kickstart our collaboration with the science and technology giant!Related news: https://www.merckgroup.com/tw-zh/news/hmil-startup-enters-mic-accelerator2020.html?fbclid=IwAR338Ry0rd8ExTG1t4h1TD6mzdArCMB57FR9kuj636WlkSi-S3hL8StyxuAhttps://tw.finance.appledaily.com/realtime/20191215/1677608https://udn.com/news/story/7240/4228380
Contact
Us
Share
